LCI Overview
Upcoming Projects (LCI)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (LCI)
Upcoming & Overdue Catalysts (LCI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (LCI)
-
Lannett (LCI) Announces FDA Approval Of NDA For Numbrino - Cocaine Hydrochloride Nasal Solution 4%, an Anesthetic
Ticker: LCI
Occurred on: Jan 13, 2020 -
FDA Approves Lannett's (LCI) Abbreviated New Drug Application for a Generic Version of Allergan's (AGN) Dementia Medication Namenda
Ticker: LCI
Occurred on: Nov 14, 2016 -
Lannett (LCI) Receives FDA Approval for Buprenorphine and Naloxone Sublingual Tablets in Treatment of Opioid Addiction
Ticker: LCI
Occurred on: Sep 20, 2016 -
Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg
Ticker: LCI
Occurred on: Jun 13, 2016 -
Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg
Ticker: LCI
Occurred on: Feb 22, 2016 -
Lannett Receives FDA Approval For Temozolomide Capsules
Ticker: LCI
Occurred on: Feb 11, 2016
Strategic Initiatives (LCI)
